SCHEMBL209944

SCHEMBL209944

O[C@@H]1COC[C@H]1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13660720 1.00
SCHEMBL209943 1.00
SCHEMBL29016131 1.00 THRB (0.41)
SCHEMBL196429 1.00
SCHEMBL209942 1.00
SCHEMBL23284422 1.00
Hydrochloric Acid SCHEMBL28195227 0.96
SCHEMBL4580880 0.87 FUCA1 (0.39)
SCHEMBL846334 0.87 FUCA1 (0.39)
Bicarbonate SCHEMBL10392138 0.86 THRB (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115181147-B Preparation method of C4 '-trifluoromethylthio modified nucleoside and C4' -trifluoromethylthio modified nucleic acid 南开大学 2024-04-02 CN claimed
CN-115181147-A Preparation method of C4 '-trifluoromethylthio modified nucleoside and C4' -trifluoromethylthio modified nucleic acid 南开大学 2022-10-14 CN claimed
EP-3034519-B1 Improved gas phase process for the polymerization of olefins BASELL POLIOLEFINE ITALIA SRL (IT) 2018-07-18 EP claimed
EP-0667245-A1 Recording sheets containing alcohols and saccharides XEROX CORPORATION (US) 1995-08-16 EP claimed
EP-0115293-B1 PROCESS FOR THE PREPARATION OF SHAPED ARTICLES ON THE BASIS OF POLYURETHANE ELASTOMERS BY THE USE OF DIOLS OF THE ANHYDRO-TETRITOL SERIES BAYER AG (DE) 1989-02-22 EP claimed
US-4476253-A Process for the preparation of polyurethane elastomers using diols of the anhydro-tetritol series BAYER AKTIENGESELLSCHAFT (DE) 1984-10-09 US claimed
EP-4211119-B1 2-AMINOQUINAZOLINES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF MERCK SHARP & DOHME LLC (US) 2026-05-13 EP disclosed
EP-4355748-B1 SUBSTITUTED PYRROLO[2,3-D]PYRIMIDINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI SA (FR) 2026-05-13 EP disclosed
US-12570640-B2 2-aminoquinazolines as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof MERCK SHARP & DOHME LLC (US) 2026-03-10 US disclosed
US-12540131-B2 N-(heteroaryl) quinazolin-2-amine derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof MERCK SHARP & DOHME LLC (US) 2026-02-03 US disclosed
WO-2025089393-A1 METHOD FOR SYNTHESIZING 1,4-ANHYDROTHREITOL 三菱瓦斯化学株式会社 2025-05-01 WO disclosed
US-20240383901-A1 SUBSTITUTED PYRROLO[2,3-D]PYRIMIDINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI (FR) 2024-11-21 US disclosed
EP-3389599-B1 ORAL CARE FORMULATION AND METHOD FOR THE REMOVAL OF TARTAR AND PLAQUE FROM TEETH GONTARZ JOHN A (US) 2024-07-17 EP disclosed
US-20030035917-A1 Image making medium HYMAN SYDNEY (US) 2003-02-20 US disclosed
US-5912247-A BLOOD FLOW INHIBITION; SIDE EFFECT REDUCTION KANEBO, LTD. (JP) 1999-06-15 US disclosed
EP-0743308-A2 Quinazoline compound and anti-tumor agent containing said compound as an active ingredient KANEBO, LTD. (JP) 1996-11-20 EP disclosed
EP-0233602-B1 CHIRAL REACTION PRODUCTS OF MESOGENIC MOLECULAR COMPONENTS AND BIFUNCTIONALLY REACTIVE BUTANE-TETRAOL DERIVATIVES AND THEIR USE AS DOPING AGENTS FOR LIQUID CRYSTAL PHASES HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-29 EP disclosed
US-4968820-A TWISTABLE HOECHST AKTIENGESELLSCHAFT (DE) 1990-11-06 US disclosed
EP-0233602-A2 Chiral reaction products of mesogenic molecular components and bifunctionally reactive butane-tetraol derivatives and their use as doping agents for liquid crystal phases HOECHST AKTIENGESELLSCHAFT (DE) 1987-08-26 EP disclosed
US-4476253-A Process for the preparation of polyurethane elastomers using diols of the anhydro-tetritol series BAYER AKTIENGESELLSCHAFT (DE) 1984-10-09 US disclosed